179 related articles for article (PubMed ID: 23138506)
1. The use of weighted and scored risk assessment models for venous thromboembolism.
Spyropoulos AC; McGinn T; Khorana AA
Thromb Haemost; 2012 Dec; 108(6):1072-6. PubMed ID: 23138506
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
Thaler J; Ay C; Pabinger I
Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
[TBL] [Abstract][Full Text] [Related]
3. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients.
Woller SC; Stevens SM; Jones JP; Lloyd JF; Evans RS; Aston VT; Elliott CG
Am J Med; 2011 Oct; 124(10):947-954.e2. PubMed ID: 21962315
[TBL] [Abstract][Full Text] [Related]
4. New paradigms in venous thromboprophylaxis of medically ill patients.
Spyropoulos AC; Raskob GE
Thromb Haemost; 2017 Aug; 117(9):1662-1670. PubMed ID: 28640324
[TBL] [Abstract][Full Text] [Related]
5. External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).
Mahan CE; Liu Y; Turpie AG; Vu JT; Heddle N; Cook RJ; Dairkee U; Spyropoulos AC
Thromb Haemost; 2014 Oct; 112(4):692-9. PubMed ID: 24990708
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.
Stuck AK; Spirk D; Schaudt J; Kucher N
Thromb Haemost; 2017 Apr; 117(4):801-808. PubMed ID: 28150851
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
[TBL] [Abstract][Full Text] [Related]
8. Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients.
Pannucci CJ; Obi A; Alvarez R; Abdullah N; Nackashi A; Hu HM; Bahl V; Henke PK
J Am Coll Surg; 2014 May; 218(5):898-904. PubMed ID: 24680577
[TBL] [Abstract][Full Text] [Related]
9. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
Wiseman DN; Harrison J
N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
[TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
Pabinger I; Ay C
Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
[TBL] [Abstract][Full Text] [Related]
11. Risk Assessment Models for Venous Thromboembolism in Medical Inpatients.
Häfliger E; Kopp B; Darbellay Farhoumand P; Choffat D; Rossel JB; Reny JL; Aujesky D; Méan M; Baumgartner C
JAMA Netw Open; 2024 May; 7(5):e249980. PubMed ID: 38728035
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
Prandoni P; Samama MM
Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
[TBL] [Abstract][Full Text] [Related]
13. External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model.
Spyropoulos AC; Eldredge JB; Anand LN; Zhang M; Qiu M; Nourabadi S; Rosenberg DJ
Oncologist; 2020 Jul; 25(7):e1083-e1090. PubMed ID: 32017293
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three risk assessment methods for venous thromboembolism prophylaxis.
Bikdeli B; Sharif-Kashani B; Shahabi P; Raeissi S; Shahrivari M; Shoraka AR; Behzadnia N; Saliminejad L
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):157-63. PubMed ID: 23314387
[TBL] [Abstract][Full Text] [Related]
15. External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.
Rosenberg D; Eichorn A; Alarcon M; McCullagh L; McGinn T; Spyropoulos AC
J Am Heart Assoc; 2014 Nov; 3(6):e001152. PubMed ID: 25404191
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment model.
Laporte S; Mismetti P
Crit Care Med; 2010 Feb; 38(2 Suppl):S10-7. PubMed ID: 20083908
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism following primary total hip arthroplasty.
Hitos K; Fletcher JP
Int Angiol; 2009 Jun; 28(3):215-21. PubMed ID: 19506541
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the use of venous thromboembolism prophylaxis in hospitalised medical patients.
Panju M; Raso D; Patel A; Panju A; Ginsberg J
J R Coll Physicians Edinb; 2011 Dec; 41(4):304-8. PubMed ID: 22184567
[TBL] [Abstract][Full Text] [Related]
19. Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.
Louzada ML; Carrier M; Lazo-Langner A; Dao V; Kovacs MJ; Ramsay TO; Rodger MA; Zhang J; Lee AY; Meyer G; Wells PS
Circulation; 2012 Jul; 126(4):448-54. PubMed ID: 22679142
[TBL] [Abstract][Full Text] [Related]
20. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
Merli GJ
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
